Antibody response to embryonal carcinoma cells in syngeneic mice
✍ Scribed by Marline Damonneville; Dominique Morello; Gabriel Gachelin; Marc Stanislawski
- Publisher
- John Wiley and Sons
- Year
- 1979
- Tongue
- English
- Weight
- 668 KB
- Volume
- 9
- Category
- Article
- ISSN
- 0014-2980
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Abstract Intravenous injection of fluorescein isothiocyanate‐modified syngeneic spleen cells (FITC‐SSC) into mice induced T cell‐independent, anti‐hapten plaque‐forming cell responses. In contrast to the high immunogenicity of FITC‐coupled SSC or bone marrow cells, thymus, lymph node or peritone
FVBN202 mice, which are transgenic for the rat neu gene, spontaneously develop mammary carcinomas between 6 and 7 months of age. We investigated whether these spontaneous tumors (spontaneous breast carcinoma cells, SBCC) could elicit an immune response in naive 6-to 8-week-old FVBN202 transgenic and
## Abstract A micro‐cytotoxic assay has been used to follow the course of the cell‐mediated response to a tumour xenograft in normal and ALS‐treated mice. In normal mice a peak response was seen at day 10 in both lymph nodes and spleen. Further peaks of cytotoxic activity were seen at days 18 and 4
## RESULTS. The relative uptake of G250 in NU-12 tumors was very high at low protein doses (125% injected dose/g [%ID/g]), but decreased at higher doses, suggesting